Population
A 62-year-old Asian female with progression from WDLPS to DDLPS
Design
Case report
Authors
Loading...
Hypothesis-generating for ROS1-targeted therapy in DDLPS; leaves open validation in larger prospective cohorts.
Whole-exome sequencing of recurrent liposarcoma identified a novel POC1B::ROS1 fusion and highlighted the genomic evolution from WDLPS to DDLPS, suggesting a potential role for targeted combination therapy.
Zhao et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: